TRPV1 and psoriasis: In a recent study using a transgenic experimental mouse model, it was found that peripheral TRPV1+ neuron activation, by isolated stimulation, is able to trigger psoriasis-like dermatitis and type 17 inflammation by local TCR γδ T cells, which can be blocked by botulinum neurotoxin A (BoNT/A) (96).